Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

pure red-cell aplasia (PRCA) - Clinical Profile, Genes & Research | Kisho | Kisho

Rare Disease

pure red-cell aplasia

MONDO:0001705

Also known as:PRCAPure Red Cell Aplasia, Acquiredprimary red cell aplasia

Find Clinical TrialsTrials

Overview

A disease characterized by normocytic, normochromic anemia, low hematocrit, reticulocytopenia, and selective erythroid hypoplasia.

Clinical Trials5 registered · 2 recruiting

Diagnosis

Biomarker and diagnostic research for pure red-cell aplasia has been reported in the published literature.

Research Landscape

Sourced from ClinicalTrials.gov and PubMed. Publication types are classified using NLM-curated article metadata; research type breakdowns reflect the nature of published work for this disease.

5 clinical trials registered, 2 recruiting. Interventions under study include drug therapy, procedural interventions, other interventions, and biologic therapy. Pipeline includes 4 PHASE2. Research is primarily sponsored by academic and government institutions.

NCT ID	Title	Phase	Sponsor	Status
[NCT07031115](https://clinicaltrials.gov/study/NCT07031115)

Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 9:39 PM UTC

MONDOHPOClinicalTrials.govFDAPubMedHGNCClinVarClinGenGeneReviewsOrphanetOMIMRUSP

Medical References

External Resources

GARD

Genetic and Rare Diseases Info Center

GARD:7504

Questions for Your Care Team

→Are any of the 5 active clinical trials a good fit for my situation?
→Are there specialists or centers of excellence for this condition in my area?
→Is there a patient registry I should consider joining?

← Back to All Diseases

Research Type	Count	% of Total
Patient case studies	49	46%
Research summaries	24	22%
Laboratory research	11	10%
Disease patterns and progression	11	10%
Other research	5	5%
Clinical study results	5	5%
Testing and diagnosis research	1	1%
New treatment approaches	1	1%

Kisho

pure red-cell aplasia

Overview

Diagnosis

Research Landscape

Medical References

External Resources

GARD

Questions for Your Care Team

Questions for Your Care Team

Recent Publications

Latest News & Developments

Acquired Pure Red Cell Aplasia Secondary to Indolent Mature T-cell Lymphoid Malignancy.

Post-COVID-19 pure red cell aplasia: A case report and literature review.

Roxadustat in the Treatment of Pure Red Cell Aplasia Associated With Anti-EPO Antibodies.

pure red-cell aplasia

Overview

Diagnosis

Research Landscape

Medical References

External Resources

GARD

Related Diseases

Questions for Your Care Team

Questions for Your Care Team

Recent Publications

Latest News & Developments

Acquired Pure Red Cell Aplasia Secondary to Indolent Mature T-cell Lymphoid Malignancy.

Post-COVID-19 pure red cell aplasia: A case report and literature review.

Roxadustat in the Treatment of Pure Red Cell Aplasia Associated With Anti-EPO Antibodies.